News

The new improved Columbus 2.3 system is believed to provide faster and more powerful high content analysis-based research applications. The platform will now help scientists perform their high

The technology used to build Chiromics’ libraries, employs a chemical synthesis technique referred to as ‘cascade catalysis.’ According to the company, cascade catalysis helps create a diverse collection

MM-151 is an oligoclonal therapeutic consisting of a mixture of three fully human monoclonal antibodies designed to bind to non-overlapping epitopes of the epidermal growth factor receptor (EGFR).

As per the collaboration, Camurus has granted Novartis an option to license the FluidCrystal Injection depot technology to develop, manufacture and commercialize Camurus’ octreotide product CAM2029 and related

The new solution, QTinno is intended to be used for an upcoming Thorough QT trial. According to the company, QTinno 3-D ECG software technology is a novel, fully

The national chain will be carrying two BluScience SKUs (HeartBlu and EternalBlu) by the end of first quarter of 2012. Two additional SKUs (MemoryBlu and Blu2Go) will also

The manufacturing plant is expected to produce critical care injectable and oncological drugs and begin operations in 2015. The 210 acres facility that previously belonged to Pfizer will

The test is intended to identify non-small cell lung cancer (NSCLC) patients with anaplastic lymphoma receptor tyrosinekinase (ALK) gene rearrangements who may benefit from Pfizer’s XalkorI (crizotinib). The

As per the agreement, the US rights to the Resolor trademark will be transferred to Shire. Resolor is approved for use in 33 countries for the symptomatic treatment